184 related articles for article (PubMed ID: 8824865)
1. Geographic determinants of leprosy in Karonga District, Northern Malawi.
Sterne JA; Pönnighaus JM; Fine PE; Malema SS
Int J Epidemiol; 1995 Dec; 24(6):1211-22. PubMed ID: 8824865
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
[TBL] [Abstract][Full Text] [Related]
3. Extended schooling and good housing conditions are associated with reduced risk of leprosy in rural Malawi.
Ponnighaus JM; Fine PE; Sterne JA; Malema SS; Bliss L; Wilson RJ
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):345-52. PubMed ID: 7963906
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of BCG against leprosy in Northern Malawi.
Fine PE; Ponnighaus JM; Maine N; Clarkson JA; Bliss L
Lancet; 1986 Aug; 2(8505):499-502. PubMed ID: 2875247
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis prevention: where do we go from here?
Warndorff DK
Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
[TBL] [Abstract][Full Text] [Related]
6. Is HIV infection a risk factor for leprosy?
Pönnighaus JM; Mwanjasi LJ; Fine PE; Shaw MA; Turner AC; Oxborrow SM; Lucas SB; Jenkins PA; Sterne JA; Bliss L
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):221-8. PubMed ID: 2071978
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
[TBL] [Abstract][Full Text] [Related]
8. Disabilities in leprosy patients ascertained in a total population survey in Karonga District, northern Malaŵi.
Ponnighaus IM; Boerrigter G; Fine PE; Ponnighaus JM; Russell J
Lepr Rev; 1990 Dec; 61(4):366-74. PubMed ID: 2280658
[TBL] [Abstract][Full Text] [Related]
9. Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?
Sterne JA; Fine PE; Pönnighaus JM; Sibanda F; Munthali M; Glynn JR
Tuber Lung Dis; 1996 Apr; 77(2):117-23. PubMed ID: 8762845
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiological studies of leprosy in northern Malawi based on an enzyme-linked immunosorbent assay using synthetic glycoconjugate antigen.
Fine PE; Ponnighaus JM; Burgess P; Clarkson JA; Draper CC
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):243-54. PubMed ID: 3045222
[TBL] [Abstract][Full Text] [Related]
12. The distribution and implications of BCG scars in northern Malawi.
Fine PE; Ponnighaus JM; Maine N
Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya.
Schellenberg JA; Newell JN; Snow RW; Mung'ala V; Marsh K; Smith PG; Hayes RJ
Int J Epidemiol; 1998 Apr; 27(2):323-9. PubMed ID: 9602418
[TBL] [Abstract][Full Text] [Related]
14. What has Karonga taught us? Tuberculosis studied over three decades.
Crampin AC; Glynn JR; Fine PE
Int J Tuberc Lung Dis; 2009 Feb; 13(2):153-64. PubMed ID: 19146741
[TBL] [Abstract][Full Text] [Related]
15. Incidence of HIV-1 infection in a rural region of Uganda.
Wawer MJ; Sewankambo NK; Berkley S; Serwadda D; Musgrave SD; Gray RH; Musagara M; Stallings RY; Konde-Lule JK
BMJ; 1994 Jan; 308(6922):171-3. PubMed ID: 8312767
[TBL] [Abstract][Full Text] [Related]
16. Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi.
Fine PE; Ponnighaus JM
Trans R Soc Trop Med Hyg; 1988; 82(6):810-7. PubMed ID: 3076995
[TBL] [Abstract][Full Text] [Related]
17. Household and dwelling contact as risk factors for leprosy in northern Malawi.
Fine PE; Sterne JA; Pönnighaus JM; Bliss L; Saui J; Chihana A; Munthali M; Warndorff DK
Am J Epidemiol; 1997 Jul; 146(1):91-102. PubMed ID: 9215227
[TBL] [Abstract][Full Text] [Related]
18. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi.
Fitness J; Floyd S; Warndorff DK; Sichali L; Mwaungulu L; Crampin AC; Fine PE; Hill AV
Am J Trop Med Hyg; 2004 Sep; 71(3):330-40. PubMed ID: 15381816
[TBL] [Abstract][Full Text] [Related]
19. Distribution of environmental mycobacteria in Karonga District, northern Malawi.
Chilima BZ; Clark IM; Floyd S; Fine PE; Hirsch PR
Appl Environ Microbiol; 2006 Apr; 72(4):2343-50. PubMed ID: 16597928
[TBL] [Abstract][Full Text] [Related]
20. The spatial distribution of leprosy cases during 15 years of a leprosy control program in Bangladesh: an observational study.
Fischer E; Pahan D; Chowdhury S; Richardus J
BMC Infect Dis; 2008 Sep; 8():126. PubMed ID: 18811971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
